Literature DB >> 19470479

Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti.

Misato Yoshikawa1, Shinji Go, Kotaro Takasaki, Yasuhiro Kakazu, Mitsuru Ohashi, Masakazu Nagafuku, Kazuya Kabayama, Junji Sekimoto, Shun-ichi Suzuki, Kazutaka Takaiwa, Takashi Kimitsuki, Nozomu Matsumoto, Shizuo Komune, Daisuke Kamei, Masaki Saito, Michihiro Fujiwara, Katsunori Iwasaki, Jin-ichi Inokuchi.   

Abstract

The ganglioside GM3 synthase (SAT-I), encoded by a single-copy gene, is a primary glycosyltransferase for the synthesis of complex gangliosides. In SAT-I null mice, hearing ability, assessed by brainstem auditory-evoked potentials (BAEP), was impaired at the onset of hearing and had been completely lost by 17 days after birth (P17), showing a deformity in hair cells in the organ of Corti. By 2 months of age, the organ of Corti had selectively and completely disappeared without effect on balance or motor function or in the histology of vestibule. Interestingly, spatiotemporal changes in localization of individual gangliosides, including GM3 and GT1b, were observed during the postnatal development and maturation of the normal inner ear. GM3 expressed in almost all regions of cochlea at P3, but at the onset of hearing it distinctly localized in stria vascularis, spiral ganglion, and the organ of Corti. In addition, SAT-I null mice maintain the function of stria vascularis, because normal potassium concentration and endocochlear potential of endolymph were observed even when they lost the BAEP completely. Thus, the defect of hearing ability of SAT-I null mice could be attributed to the functional disorganization of the organ of Corti, and the expression of gangliosides, especially GM3, during the early part of the functional maturation of the cochlea could be essential for the acquisition and maintenance of hearing function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470479      PMCID: PMC2695060          DOI: 10.1073/pnas.0903279106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  The glycosynapse.

Authors:  Sen-itiroh Hakomori Si
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 2.  K+ cycling and the endocochlear potential.

Authors:  Philine Wangemann
Journal:  Hear Res       Date:  2002-03       Impact factor: 3.208

3.  Compartmentalization established by claudin-11-based tight junctions in stria vascularis is required for hearing through generation of endocochlear potential.

Authors:  Shin-ichiro Kitajiri; Tatsuo Miyamoto; Akihito Mineharu; Noriyuki Sonoda; Kyoko Furuse; Masaki Hata; Hiroyuki Sasaki; Yoshiaki Mori; Takahiro Kubota; Juichi Ito; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2004-10-01       Impact factor: 5.285

Review 4.  Histochemistry of glycoconjugates of the auditory receptor-functional implications.

Authors:  P Gil-Loyzaga
Journal:  Prog Histochem Cytochem       Date:  1997

5.  Enhanced insulin sensitivity in mice lacking ganglioside GM3.

Authors:  Tadashi Yamashita; Akira Hashiramoto; Martin Haluzik; Hiroki Mizukami; Shoshannah Beck; Aaron Norton; Mari Kono; Shuichi Tsuji; Jose Luis Daniotti; Norbert Werth; Roger Sandhoff; Konrad Sandhoff; Richard L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

6.  Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures.

Authors:  H Kawai; M L Allende; R Wada; M Kono; K Sango; C Deng; T Miyakawa; J N Crawley; N Werth; U Bierfreund; K Sandhoff; R L Proia
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

7.  KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential.

Authors:  Daniel C Marcus; Tao Wu; Philine Wangemann; Paulo Kofuji
Journal:  Am J Physiol Cell Physiol       Date:  2002-02       Impact factor: 4.249

8.  Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside.

Authors:  Masahiro Inoue; Yuko Fujii; Keiko Furukawa; Masahiko Okada; Kenji Okumura; Tetsuo Hayakawa; Koichi Furukawa; Yasuo Sugiura
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

9.  Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death.

Authors:  Martine Cohen-Salmon; Thomas Ott; Vincent Michel; Jean Pierre Hardelin; Isabelle Perfettini; Michel Eybalin; Tao Wu; Daniel C Marcus; Philine Wangemann; Klaus Willecke; Christine Petit
Journal:  Curr Biol       Date:  2002-07-09       Impact factor: 10.834

10.  Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential.

Authors:  Barbara Teubner; Vincent Michel; Jörg Pesch; Jürgen Lautermann; Martine Cohen-Salmon; Goran Söhl; Klaus Jahnke; Elke Winterhager; Claus Herberhold; Jean-Pierre Hardelin; Christine Petit; Klaus Willecke
Journal:  Hum Mol Genet       Date:  2003-01-01       Impact factor: 6.150

View more
  43 in total

1.  Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases.

Authors:  Matthew S Macauley; Britni M Arlian; Cory D Rillahan; Poh-Choo Pang; Nikki Bortell; Maria Cecilia G Marcondes; Stuart M Haslam; Anne Dell; James C Paulson
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

Review 2.  Structures, biosynthesis, and functions of gangliosides--an overview.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga; Makoto Yanagisawa
Journal:  J Oleo Sci       Date:  2011       Impact factor: 1.601

Review 3.  Stem cell glycolipids.

Authors:  Makoto Yanagisawa
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

4.  CD4 and CD8 T cells require different membrane gangliosides for activation.

Authors:  Masakazu Nagafuku; Kaori Okuyama; Yuri Onimaru; Akemi Suzuki; Yuta Odagiri; Tadashi Yamashita; Katsunori Iwasaki; Michihiro Fujiwara; Motoaki Takayanagi; Isao Ohno; Jin-ichi Inokuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

5.  Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice.

Authors:  Mei-Hong Lu; Makoto Takemoto; Ken Watanabe; Huan Luo; Masataka Nishimura; Masato Yano; Hidekazu Tomimoto; Toshiro Okazaki; Yuichi Oike; Wen-Jie Song
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

6.  Expression machinery of GM4: the excess amounts of GM3/GM4S synthase (ST3GAL5) are necessary for GM4 synthesis in mammalian cells.

Authors:  Satoshi Uemura; Shinji Go; Fumi Shishido; Jin-ichi Inokuchi
Journal:  Glycoconj J       Date:  2013-09-03       Impact factor: 2.916

7.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

8.  Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy mice.

Authors:  Kei-Ichiro Inamori; Hideki Ito; Yumi Tamura; Takahiro Nitta; Xiaohua Yang; Wataru Nihei; Fumi Shishido; Susumu Imazu; Sohei Tsukita; Tetsuya Yamada; Hideki Katagiri; Jin-Ichi Inokuchi
Journal:  J Lipid Res       Date:  2018-06-07       Impact factor: 5.922

9.  Identification of a new liver-specific c-type mRNA transcriptional variant for mouse ST3GAL5 (GM3/GM4 synthase).

Authors:  Fumi Shishido; Satoshi Uemura; Takahiro Nitta; Jin-Ichi Inokuchi
Journal:  Glycoconj J       Date:  2017-08-14       Impact factor: 2.916

Review 10.  Human genetic disorders of sphingolipid biosynthesis.

Authors:  Leonardo Astudillo; Frédérique Sabourdy; Nicole Therville; Heiko Bode; Bruno Ségui; Nathalie Andrieu-Abadie; Thorsten Hornemann; Thierry Levade
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.